AI-generated summary
The authors measured MT-CO2 and SDHB protein levels in postmortem temporal cortex from people with Alzheimer's disease and other conditions, and tested photobiomodulation in neuroblastoma cells. They report that MT-CO2 was lower in Alzheimer's than in cognitively normal and Lewy body/Parkinson's groups, and that red and near-infrared light increased MT-CO2 in cells. Because the tissue findings cannot separate general mitochondrial loss from protein-specific changes, the interpretation is limited.
- Who or what was studied
- Postmortem temporal cortex from cognitively normal individuals and patients with Alzheimer's disease, Lewy body dementia/Parkinson's disease, or progressive supranuclear palsy; BE(2)-C neuroblastoma cells for the photobiomodulation experiments
- Wavelengths
- 650, 808 nm
- Limits stated in the abstract
- Mitochondrial content was not independently measured, so the tissue findings cannot distinguish broader mitochondrial loss from protein-specific dysregulation.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on mdpi.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 650 nm, 808 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Near-infrared, Cytochrome c oxidase, Dementia. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.